OPKO Acquires Next Generation Dry Powder Inhaler to Treat Respiratory Disorders

Posted by on Apr 18, 2014 in Newsroom | 0 comments

MIAMI, FL. - OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd. (“Inspiro”), an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro’s Inspiromatic™ is a “smart” easy-to-use dry powder inhaler with several advantages over existing devices. “We are pleased to add this next generation inhaler to OPKO’s growing product portfolio” Inspiromatic™ offers improved drug deposition to the lower airways of...

Read More

SCRA Technology Ventures Presents “Big Check” Investment

Posted by on Apr 18, 2014 in Newsroom | 0 comments

COLUMBIA, S.C. - SCRA’s Technology Ventures’ SC Launch program presented a “big check” investment last night to Senex Biotechnology during the Center for Entrepreneurial and Technological Innovation (CETi) at USC Start! Innovation Series networking event. The Start! Innovation Series invites aspiring entrepreneurs and innovators to connect, learn and grow their ventures. Senex Biotechnology, located in Columbia, is a drug discovery company with technology that targets a signaling pathway which is activated by cellular damage and is involved in cell senescence, or...

Read More

Eventus Diagnostics obtains $2.7M from investors

Posted by on Apr 18, 2014 in Newsroom | 0 comments

MIAMI, FL - As the gold standard for breast cancer screening has come under scrutiny in recent years, a new class of imaging devices, antibody tests and gene tests to detect breast cancer has been making its way through the pipeline. One of those is a blood biomarker test that Eventus Diagnostics says could potentially help physicians identify false negative and false positive mammogram results. EventusDx has just closed in on a $2.7 million round of financing from undisclosed investors to move forward with a large international clinical study that would support its application for FDA...

Read More

Iconic Therapeutics snags $20M

Posted by on Apr 17, 2014 in Newsroom | 0 comments

ATLANTA, GA. and SOUTH SAN FRANCISCO, CA. — Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic’s lead clinical-stage program is a novel recombinant human chimeric protein therapeutic, hI-con1, licensed from Yale University. hI-con1 binds tissue factor, a promoter of inflammation and angiogenesis, key processes underlying the pathogenesis of age-related...

Read More

eTect Receives Follow-on Funding from Florida Technology Seed Capital Fund

Posted by on Apr 10, 2014 in Newsroom | 0 comments

BOCA RATON & GAINESVILLE, FL. - The Florida Technology Seed Capital Fund, LLC (Seed Capital Fund), a subsidiary of the Institute for Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with eTect, developers of the ID-Cap, a capsule that enables real time monitoring of medication compliance by emitting a digital wireless message when it is ingested by a patient. The Institute works with Florida research universities and institutions to support new company creation and job growth, and provides seed funding to qualified...

Read More

Alabama State University garners federal grant for nanotechnology student research

Posted by on Apr 8, 2014 in Newsroom | 0 comments

MONTGOMERY, Alabama – Alabama State University announced today it has garnered a $336,634 from the National Science Foundation to host its Research Experience for Undergraduates program. The REU program will host 10 undergraduate students for 10 weeks in a summer program that will provide hands-on research experience in nanotechnology and biotechnology, said Komal Vig, the principal investigator of the ASU research program. Nanotechnology devices are so small they fit on the end of a human hair. They may be used to implant medicines and medical devices into the human body and a variety...

Read More